MARKET OVERVIEW

The global Lactase Market reached a size of USD 273.2 Million in 2024. It is forecast to grow to USD 456.9 Million by 2033, expanding at a CAGR of 5.41% during the period 2025–2033. This growth is driven by the increasing prevalence of lactose intolerance, technological advances in enzyme production, and rising health awareness, alongside government support for lactose-free products and dietary supplements.

STUDY ASSUMPTION YEARS

• Base Year: 2024

• Historical Years: 2019-2024

LACTASE MARKET KEY TAKEAWAYS

• Current Market Size: USD 273.2 Million in 2024

• CAGR: 5.41%

• Forecast Period: 2025-2033

• The market is expanding globally due to a rise in lactose intolerance and shifts toward lactose-free products.

• Technological advancements, including genetically modified organisms and enzyme stabilization techniques, enhance lactase production and application.

• Food and beverages segment leads the application market, driven by increasing demand for lactose-free dairy products.

• Europe holds the largest market share owing to high lactose intolerance rates and advanced food technology.

• Increasing health awareness and supportive government policies promote the growth of lactose-free products and supplements.

Sample Request Link: https://www.imarcgroup.com/lactase-market/requestsample

MARKET GROWTH FACTORS

The increase in lactase demand worldwide, along with the producing of lactose-free dairy and dietary supplements, is the main factor for the global lactase market growth. The growing digestive health awareness combined with the intake of lactose-free products is the reason for the continuous market growth. Lactose intolerance is the direct reason for the product demand.

In the process of lactase production, technological advancements, such as the use of genetically modified microorganisms, and enzyme stabilization have made lactase production more efficient and cheaper. These innovations not only increase the yield and purity of the enzyme but also improve the life span of the product and cut down the cost of production, thus widening the application of lactase in the food and pharmaceutical industries.

Moreover, government policies and increased consumer health awareness are other factors that contribute to the growth of the market. Regulatory systems that support labeling of lactose-free products enhance consumers’ trust and manufacturers’ investments. Furthermore, campaigns that inform the public about lactose intolerance and digestive health issues, increase the demand for lactase-based products and supplements.

MARKET SEGMENTATION

• Breakup by Source:

• Fungi: Known for breaking down lactose at acidic pH, suited for food and beverage industry.

• Yeast: Represents the largest segment; used for efficient lactose hydrolysis across pH and temperature ranges, favored in lactose-free milk production.

• Bacteria: Used in fermented dairy products; effective in converting lactose to lactic acid, popular in probiotic and fermented foods.

Breakup by Form:

• Powder: Largest segment due to stability, storage convenience, and cost-effectiveness; widely used in dairy industry for lactose-free products.

• Liquid: Used mainly in liquid dairy processing; allows precise dosing and efficient lactose hydrolysis.

Breakup by Application:

• Food and Beverages: Largest segment; includes milk, cheese, yogurt, and others, driven by demand for lactose-free dairy.

• Dietary Supplements: Tablets, capsules, taken to aid digestion of lactose-containing foods; growing in popularity.

• Pharmaceuticals: Used in medications to treat lactose intolerance symptoms and improve gastrointestinal health.

Breakup by Region:

• North America: Includes United States and Canada.

• Europe: Leads market globally; includes Germany, France, United Kingdom, Italy, Spain, and others.

• Asia Pacific: Includes China, Japan, India, South Korea, Australia, Indonesia, and others.

• Latin America: Includes Brazil, Mexico, and others.

• Middle East and Africa.

REGIONAL INSIGHTS

Europe leads the lactase market due to a high prevalence of lactose intolerance, particularly in Northern Europe. Advanced food processing technology, robust R&D, and strict regulatory standards drive demand. Consumer health awareness and the EU's supportive regulatory framework for enzymes facilitate strong market growth. Europe accounts for the largest market share globally.

RECENT DEVELOPMENTS & NEWS

• November 14, 2023: Chr. Hansen Holding A/S introduced two yeast strains in SmartBev NEER technology enhancing flavors in non-alcoholic brewing, improving beer mouthfeel and process sustainability.

• September 25, 2023: Creative Enzymes launched Custom Blends product line, offering tailored enzyme, probiotic, and extract blends for diverse bioprocessing applications.

• November 30, 2023: DuPont de Nemours Inc announced North American sites now produce a low global warming potential Styrofoam Brand XPS insulation, reducing embodied carbon by 94%.

KEY PLAYERS

• Advanced Enzyme Technologies

• Antozyme Biotech Pvt Ltd

• Biolaxi Corporation

• Chr. Hansen Holding A/S

• Creative Enzymes

• DuPont de Nemours Inc

• Kerry Inc.

• Koninklijke DSM N.V.

• Merck KGaA

• Novozymes A/S

• Polttimo Oy

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1-201971-6302